Yongin Severance Hospital has recently achieved 100 cases of robotic mastectomy based on the accumulated experience of Severance Hospital, the first hospital in Korea to introduce robotic surgery.

It is a rare achievement in the field of breast cancer, as only a few top hospitals in Korea have achieved this level, according to Yongin Severance Hospital.

Yongin Severance Hospital has achieved 100 cases of robotic surgery for breast cancer.
Yongin Severance Hospital has achieved 100 cases of robotic surgery for breast cancer.

Yongin Severance Hospital has established a leading position in the field of robotic breast surgery, with experienced specialists led by Professor Kim Joo-heung of the Department of Breast Surgery, making it the second hospital in Korea to introduce robotic breast surgery.

In addition, the hospital has established a one-stop system, where the entire process of breast cancer treatment, from diagnosis to surgery, chemotherapy, and radiotherapy, is performed at a single institution, providing patients with prompt and integrated treatment services.

Robotic surgery for breast cancer requires only a four-centimeter incision through the armpit to achieve the same effect as conventional surgery, and the incision is inconspicuous, making it an important alternative for patients who are concerned about their appearance.

Professor Kim recently presented a study in JAMA Surgery, a prestigious international journal in the field of surgery, showing that robotic and endoscopic minimally invasive surgery can reduce the rate of nipple and areola necrosis by about one-third compared to conventional skin incisions, winning international recognition for the safety and effectiveness of robotic surgery for breast cancer.

“This achievement was the result of collaborating with various departments and colleagues under difficult conditions in the early days of our opening,” Professor Kim said. “We will continue to conduct research and education so that robotic surgery can become a safer and more standardized method of breast cancer treatment.”

Copyright © KBR Unauthorized reproduction, redistribution prohibited